Legal Representation
Attorney
Matthew J Himich
USPTO Deadlines
Application History
16 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| May 16, 2023 | MAB2 | E | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND | Loading... |
| May 16, 2023 | MAB2 | O | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND | Loading... |
| May 16, 2023 | ABN2 | O | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | Loading... |
| Oct 11, 2022 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Oct 11, 2022 | GNRT | O | NON-FINAL ACTION E-MAILED | Loading... |
| Oct 11, 2022 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Sep 6, 2022 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Sep 1, 2022 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Aug 31, 2022 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Aug 31, 2022 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Mar 5, 2022 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Mar 5, 2022 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Mar 5, 2022 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Mar 4, 2022 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Sep 1, 2021 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Jun 17, 2021 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 042
Consulting services in the field of pharmaceuticals and biotechnology research and development; consulting services for others in the field of design, planning, support and implementation of programs for scientific research of pharmaceuticals, laboratory testing of pharmaceuticals, diagnostics for pharmaceuticals, clinical trials of pharmaceuticals, testing, modeling and simulation of pharmaceuticals, and due diligence and audit of such programs; quality management services, namely quality evaluation and analysis, quality assurance, and quality control in the field of pharmaceutical drug manufacturing and contract manufacturing; consulting pertaining to pharmacokinetics and biostatistics; conducting scientific feasibility studies
First Use Anywhere:
0
First Use in Commerce:
0
Additional Information
Translation
The English translation of ESPERTI in the mark is EXPERTS.
Classification
International Classes
042
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
General Disclaimer
"PHARMACEUTICALS"